This video features Dr. Kevin Chung and Dr. Stuart L. Goldstein discussing QUELIMMUNE, a groundbreaking medical device developed by SeaStar Medical that has received FDA approval. Designed to treat pediatric patients suffering from acute kidney injury caused by sepsis, QUELIMMUNE is transforming childhood renal care. The experts share insights into its development, clinical studies, and potential to significantly improve treatment outcomes for children facing severe kidney conditions.